Skip to main content
Smart Investors Daily
ST

NYSE · STSEY

Stratec SE

Healthcare · Medical - Devices

$5.51

Up+$0.00 (+0.00%)

Updated Nov 20, 2026, 2:54 AM

SID Score

4.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
1.55B
P/E ratio
18.5
Dividend yield
2.55%
52-week range
— – —
Volume
100
Avg. volume
9

Price performance · STSEY

STSEY price history

1M range · 0 trading sessions · Daily adjusted prices

STSEY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest STSEY news

The latest Smart Investors Daily articles mentioning STSEY.

STSEY research

Overview

Company profile and research snapshot.

Company profile

STRATEC SE UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
STSEY recent ratings
DateFirmRatingTarget
Sep 21, 2026BERENBERGBuy—
Sep 3, 2026BAADER EUROPEBuy—
Aug 28, 2026METZLER EQUITIESBuy—
Aug 14, 2026BAADER EUROPEBuy—
Aug 14, 2026MWB RESEARCH AGHold—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Nov 12, 2026

Stratec Q3 Earnings Call Highlights

Stratec (ETR:SBS) reported higher adjusted operating profit and stronger cash generation for the first nine months of 2026 despite lower revenue, as the diagnostic systems company outlined a narrower focus following its agreement to sell its Diatron business. Revenue fell 6.1% to EUR 165 million fr

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.